載入...
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
Little observational data exist describing telbivudine (LdT) or lamivudine (LAM) use in late pregnancy for preventing hepatitis B mother-to-child transmission (MTCT) in real-world settings. During the period of January 2009 to March 2011, we enrolled hepatitis B e antigen–positive mothers with HBV D...
Na minha lista:
| 發表在: | Hepatology |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BlackWell Publishing Ltd
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4282428/ https://ncbi.nlm.nih.gov/pubmed/25187919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27034 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|